The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary edema, noncardiogenic (NCPE)
Publications
A Case of MDMA-Associated Cerebral and Pulmonary Edema Requiring ECMO.
Case reports in critical care. 2017;2017:6417012
Isolated non-cardiogenic pulmonary edema - A rare complication of MDMA toxicity.
The American journal of emergency medicine. 2017;35(9):1385.e3-1385.e6
MDMA-induced acute pulmonary edema in a patient without other organ dysfunction.
The American journal of emergency medicine. 2006;24(6):734-6
Fatal hyponatremia in a young woman after ecstasy ingestion.
Nature clinical practice. Nephrology. 2006;2(5):283-8, quiz 289
Ecstasy--deadly risk even outside rave parties.
Forensic science international. 2005;153(2-3):227-30
Our experiences with fatal ecstasy abuse (two case reports).
Forensic science international. 2005;147 Suppl:S77-80
Pulmonary oedema caused by "liquid ecstasy" ingestion.
Archives of disease in childhood. 2002;86(4):302-3